Core Viewpoint - The company is actively preparing the application materials for the new drug JJH201501 and is progressing with the subsequent processes while ensuring compliance with information disclosure obligations [1] Group 1 - The company is responding to investor inquiries regarding the status of the new drug application [1] - The company will disclose relevant information in accordance with regulations through designated media [1]

Group 1 - The company is currently preparing the necessary materials for the new drug application of JJH201501 as per relevant requirements [1]